New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics

التفاصيل البيبلوغرافية
العنوان: New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics
المؤلفون: Ania M. Jastreboff, Robert F. Kushner
المصدر: Annual Review of Medicine. 74:125-139
بيانات النشر: Annual Reviews, 2023.
سنة النشر: 2023
مصطلحات موضوعية: General Medicine, General Biochemistry, Genetics and Molecular Biology
الوصف: Nearly half of Americans are projected to have obesity by 2030, underscoring the pressing need for effective treatments. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) represent the first agents in a rapidly evolving, highly promising landscape of nascent hormone-based obesity therapeutics. With the understanding of the neurobiology of obesity rapidly expanding, these emerging entero-endocrine and endo-pancreatic agents combined or coformulated with GLP-1 RAs herald a new era of targeted, mechanism-based treatment of obesity. This article reviews GLP-1 RAs in the treatment of obesity and previews the imminent future of nutrient-stimulated hormone-based anti-obesity therapeutics.
تدمد: 1545-326X
0066-4219
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4cb96f036c63584dd326779415511f89Test
https://doi.org/10.1146/annurev-med-043021-014919Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........4cb96f036c63584dd326779415511f89
قاعدة البيانات: OpenAIRE